2?-O-Methylcytidine
| Code | Size | Price |
|---|
| TAR-T38237-100mg | 100mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
2?-O-Methylcytidine inhibits NS5B-catalyzed RNA synthesis in vitro, in a manner that is competitive with substrate nucleoside triphosphate. 2?-O-Methylcytidine inhibits HCV RNA replication.
CAS:
2140-72-9
Formula:
C10H15N3O5
Molecular Weight:
257.246
Pathway:
Proteases/Proteasome; Cell Cycle/Checkpoint; Microbiology/Virology; DNA Damage/DNA Repair
Purity:
0.98
SMILES:
CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O
Target:
Nucleoside Antimetabolite/Analog; HCV Protease
References
Migliaccio, G., Tomassini, J.E., Carroll, S.S., et al.Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitroJ. Bio. Chem.278(49)49164-49170(2003)